These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9538979

  • 1. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G, Carta Q, Deferrari G, Mangili R, Navalesi R, Santeusanio F, Spalluto A, Vanasia A, Villa GM, Nosadini R.
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [Abstract] [Full Text] [Related]

  • 2. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun 21; 349(9068):1787-92. PubMed ID: 9269212
    [Abstract] [Full Text] [Related]

  • 3. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P, Tarnow L, Boelskifte S, Jensen BR, Nielsen FS, Parving HH.
    Diabetes; 1997 Mar 21; 46(3):481-7. PubMed ID: 9032106
    [Abstract] [Full Text] [Related]

  • 4. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov 21; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects.
    Bakris GL, Slataper R, Vicknair N, Sadler R.
    J Diabetes Complications; 1994 Nov 21; 8(1):2-6. PubMed ID: 8167383
    [Abstract] [Full Text] [Related]

  • 8. Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, Raffaele J, Tsalamandris C.
    Am J Kidney Dis; 2001 May 21; 37(5):890-9. PubMed ID: 11325669
    [Abstract] [Full Text] [Related]

  • 9. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G, Allen TJ, Campbell DJ, Cooper ME, Gilbert RE, Hammond JJ, O'Brien RC, Raffaele J, Tsalamandris C, Melbourne Diabetic Nephropathy Study Group.
    Diabet Med; 2004 Nov 21; 21(11):1192-9. PubMed ID: 15498085
    [Abstract] [Full Text] [Related]

  • 10. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May 21; 39(5):587-93. PubMed ID: 8739919
    [Abstract] [Full Text] [Related]

  • 11. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy.
    Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ.
    J Intern Med; 1991 Feb 21; 229(2):163-70. PubMed ID: 1847721
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.
    O'Donnell MJ, Rowe BR, Lawson N, Horton A, Gyde OH, Barnett AH.
    J Hum Hypertens; 1993 Aug 21; 7(4):333-9. PubMed ID: 8410924
    [Abstract] [Full Text] [Related]

  • 13. Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.
    Tuominen JA, Ebeling P, Koivisto VA.
    Diabetes Care; 1998 Aug 21; 21(8):1345-8. PubMed ID: 9702445
    [Abstract] [Full Text] [Related]

  • 14. Hypertension and non-insulin-dependent diabetes. A comparison between an angiotensin-converting enzyme inhibitor and a calcium antagonist.
    Crepaldi G, Carraro A, Brocco E, Adezati L, Andreani D, Bompiani G, Brunetti P, Fedele D, Giorgino R, Giustina G.
    Acta Diabetol; 1995 Oct 21; 32(3):203-8. PubMed ID: 8590792
    [Abstract] [Full Text] [Related]

  • 15. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study.
    Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G.
    Diabetes; 1996 Dec 21; 45(12):1729-33. PubMed ID: 8922358
    [Abstract] [Full Text] [Related]

  • 16. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
    Tarnow L, Rossing P, Jensen C, Hansen BV, Parving HH.
    Diabetes Care; 2000 Dec 21; 23(12):1725-30. PubMed ID: 11128341
    [Abstract] [Full Text] [Related]

  • 17. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.
    J Hum Hypertens; 1996 Mar 21; 10(3):185-92. PubMed ID: 8733038
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J, Siddiqui MA, Ahmad H.
    Diabetes Care; 1997 Oct 21; 20(10):1576-81. PubMed ID: 9314638
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.